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■ Abstract Objective To study the
impact of co-existing psychiatric
problems with ADHD on behav-
ioural features, psychosocial
functioning and quality of life in
subjects of the ADORE cohort
(N = 1,478). Methods The following
six groups of associated psychiatric
problems with ADHD were com-
pared: oppositional-defiant disor-
der or conduct disorder only
(ODD/CD); anxiety or depressive
disorder only (ANX/DEP); tic/
Tourette’s disorder only (TIC/
Tourette’s); developmental co-ordi-
nation disorder only (DCD); two or
more associated conditions; and
none. Dependent variables in-
cluded the ADHD Rating Scale-IV,
the Strengths and Difficulties
Questionnaire, the Clinical Global
Impression-Severity scale, the Chil-
dren’s Global Assessment Scale and
the Child Health Illness Profile-
Child Edition. Results Having mul-
tiple co-existing psychiatric prob-
lems increased the severity of
ADHD in all domains, be it behav-
ioural features, psychosocial im-
pairment or deterioration of qual-
ity of life. A similar though less
consistent pattern applied to sub-
jects with co-existing ODD/CD.
Conclusions The ADORE study
provides impressive evidence for
the far-reaching consequences of
co-existing psychiatric problems in
children with ADHD that warrant
intensive consideration in clinical
assessment and treatment.
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Abbreviations
ADHD Attention-Deficit/Hyperactivity Disor-
der
ADORE Attention-deficit/hyperactivity Disor-
der Observational Research in Europe
ADHD-RS-IV ADHD Rating Scale-IV
ANX Anxiety
CD Conduct Disorder
CHIP-CE Child Health and Illness Profile – Child
Edition
CGAS Children’s Global Assessment Scale
CGI-S Clinical Global Impression-Severity
scale
DCC Developmental Co-ordination Disorder
ODD Oppositional Defiant Disorder
RD Reading Disabilities
SDQ Strengths and Difficulties Questionnaire
SLD Specific Learning Disorder
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Introduction
Co-morbidity is a common phenomenon in medicine.
However, the application of the term “co-morbidity” to
psychopathology is problematic because it is meaningful
only in the context of well-validated disease entities with
reasonably well-understood pathology and aetiology.
“Co-existence” or “co-variation” would be more appro-
priate terms to use in psychopathology. This is particu-
larly true for the ADORE study because clinical ratings
of associated mental problems were made rather than
detailed clinical assessments of additional psychiatric
disorders.However,the distinction between co-existence
and co-morbidity has rarely been made in the literature.
Both large-scale epidemiological surveys [3, 16, 27]
and the MTA study [13] have shown that co-existing
problems are frequent in ADHD.A large number of clin-
ical studies have found that co-existing oppositional de-
fiant (ODD) and conduct disorder (CD) are common
(occurring in more than 50 % of cases); specific learning
disorders (SLD), anxiety disorders (ANX) and develop-
mental co-ordination disorders (DCD) are frequent (oc-
curring in up to 50 % of cases); tic disorders and de-
pressive disorders are occasionally present (in up to
20 % of cases); and autism spectrum disorders and men-
tal retardation are infrequent.Over 85 % of patients with
ADHD have at least one co-existing psychiatric condi-
tion and approximately 60 % of patients have at least two
co-existing conditions. Thus, in clinical practice, co-ex-
isting psychiatric problems are the rule rather than the
exception.
Co-existing problems in ADHD have implications for
research. For example, there is sufficient evidence to de-
lineate two new sub-classifications of ADHD: (a) ADHD
aggressive subtype; and (b) ADHD anxious subtype
[14]. Findings from neurophysiological studies support
the validity of the aggressive or externalising subtype of
ADHD [2, 4]. In addition, family genetic and prevalence
studies point to the genetic and phenotypic heterogene-
ity of ADHD [9],and behavioural genetic studies are try-
ing to identify the genetic liability of various co-existing
conditions, e.g. ODD/CD [6, 7, 18] or SLD, namely, read-
ing disability (RD) [28]. With recent advances in molec-
ular genetics, the search for specific candidate genes has
provided initial insights that genes can affect several
disorders and functions, e. g. in ADHD and RD [29], or
ADHD and autism [26].
Most importantly, the co-existence of ADHD with
other psychiatric problems has strong implications for
clinical practice.Physicians are not only confronted with
rather complex conditions for referral and assessment,
but also face the challenge of developing adequate treat-
ment guidelines [19] and intervention schemes [1, 13].
Effective interventions are particularly important be-
cause there is evidence from research that co-existing
forms of psychopathology in children and adolescents
are associated with increased psychosocial impairment
[17]. So far, psychosocial impairment has not been well
studied in ADHD. Thus, the ADORE study with its large
sample size, rich cultural diversity and longitudinal
structure, allows study of the impact of various co-exis-
tent psychiatric problems with ADHD on clinical fea-
tures, behavioural dimensions, psychosocial function-
ing and quality of life. The present analysis of the impact
of ADHD and co-existing psychiatric problems is based
on the results of the various scales measured at the base-
line assessment of the ADORE cohort.
Methods
The background, rationale and design of the ADORE
study on 1,478 children with ADHD have been described
in detail in a previous paper [21], and the baseline char-
acteristics of the study population are reported in a sep-
arate paper of this issue [20]. In the present analysis, we
have divided the subjects with ADHD into the following
six groups according to the absence or presence of co-
existing psychiatric problems: (a) ADHD only (N = 471),
(b) ADHD with ANX/DEP (N = 59), (c) ADHD with
ODD/CD (N = 244), (d) ADHD with TIC/Tourette’s
(N = 33), (e) ADHD with COORD (co-ordination prob-
lems) (N = 200),and (f) ADHD with two or more of these
conditions (N = 363). Anxiety, depression, CD and ODD
were defined by clinical ratings based on a 7-point Likert
scale, whereas tic disorders and co-ordination problems
were assessed as either ‘present’ or ‘not present’.A co-ex-
isting problem was considered clinically significant
when rated as present or as at least moderately impaired
(i. e. score ≥ 4) on the 7-point scale.
The dependent variables in the analyses were
grouped into three domains: [1] behavioural features as
measured by the ADHD Rating Scale-IV (ADHD-RS-IV)
[8], including the overall score and the two subdomain
scores for inattention and hyperactivity-impulsivity,
and the Strengths and Difficulties Questionnaire (SDQ)
[11, 24], consisting of five subscales measuring emo-
tional symptoms, conduct problems, hyperactivity/inat-
tention, peer relationship problems, and prosocial be-
haviour; [2] psychosocial functioning, including the
Clinical Global Impression-Severity (CGI-S) scale [12]
and the Children’s Global Assessment Scale (CGAS) [25];
and [3] quality of life as measured by the Child Health
and Illness Profile-Child Edition (CHIP-CE) [22], which
is composed of the five domains of Satisfaction, Com-
fort, Risk Avoidance, Resilience and Achievement.
■ Statistical analyses
Comparisons of the six groups of subjects across each of
the three dependent variable domains (behavioural fea-
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tures, psychosocial functioning and quality of life) were
made by multivariate analyses of covariance (ANCOVA),
with gender, age and co-existing psychiatric problems
(present/absent) as covariates. These analyses were fol-
lowed by univariate ANCOVA for each individual de-
pendent variable, adjusting for multiple pairwise com-
parisons between the different subgroups of co-existing
psychiatric problems using the Tukey test to identify
homogenous subsets.
Results
In the entire ADORE sample at the baseline assessment
(N = 1,478), the distribution of co-existing symptoms of
any degree was as follows: anxiety (44 %), depression
(32 %), CD (46 %), ODD (67 %), tics (8 %), Tourette’s
(1 %) and co-ordination problems (33 %). Further co-
existing problems not considered in the present analy-
ses included obsessive compulsive disorders (2 %),
bronchial asthma (8 %) and epilepsy (less than 1 %).
A comparison of the scores across the six groups for
behavioural features (ADHD-RS-IV) and psychosocial
functioning (CGI-S and CGAS) is given in Table 1. For all
variables, the group with multiple psychiatric problems
(ADHD + ≥ 2 COND, Group F) was significantly more
impaired than the ADHD-only group (Group A) and
most other groups. A similar but less consistent pattern
emerged for the ADHD plus ODD/CD group (Group C),
which showed worse scores than the ADHD-only group
and some (though not all) of the other groups. Thus,
subjects with multiple psychiatric problems (and less
consistently those with ADHD plus ODD/CD) had
higher scores on all ADHD scales, a more severe overall
clinical picture (CGI-S) and poorer psychosocial func-
tioning (CGAS) than the other groups.
A similar picture emerged from the comparison of
the SDQ scores among the six groups, as shown in
Table 2. Again, the multiple psychiatric problems group
and the ADHD plus ODD/CD group stood out as being
different from the other groups. The multiple problems
group (Group F) showed more ‘abnormal’ scores than
the ADHD-only group (Group A) and most of the other
groups on the SDQ subscales measuring total difficul-
ties, emotional symptoms, conduct problems, hyperac-
tivity/inattention, peer relationship problems, and
prosocial behaviour. In addition, the ADHD plus
ODD/CD group (Group C) had significantly worse
scores for total difficulties, conduct problems, peer rela-
tionship problems and prosocial behaviour than the
Table 1 Adjusted mean scores for the ADHD-RS-IV, CGI-S, and CGAS scales across the six groups with co-existing disorders
ADHD-only (A) ADHD + ADHD + ADHD + TIC/ ADHD + ADHD + Homogenous subsets
ANX/DEP (B) ODD/CD (C) Tourette’s (D) COORD (E) ≥2 COND (F)
ADHD-RS-IV Overalla 33.6 (8.9) 34.2 (9.0) 37.3 (8.9) 33.9 (9.0) 34.1 (8.9) 38.8 (8.9) F > A,B,D,E; C > A,E
ADHD-RS-IV Inattention subscalea 17.9 (4.6) 19.1 (4.6) 19.1 (4.6) 17.5 (4.6) 19.0 (4.6) 20.4 (4.6) F > A,C,D,E; C > A
ADHD-RS-IV Hyperactivity-
Impulsivity subscalea 15.6 (5.9) 15.1 (5.9) 18.2 (5.9) 16.4 (6.0) 15.1 (5.9) 18.4 (5.9) C,F > A,B,E
CGI-Sa 4.1 (0.8) 4.3 (0.8) 4.6 (0.8) 4.0 (0.8) 4.1 (0.8) 4.8 (0.8) F > A,B,C,D,E; C > A,D,E
CGASb 58.5 (10.1) 55.8 (10.2) 53.3 (10.2) 54.8 (10.3) 57.2 (10.2) 50.7 (10.1) F < A,B,E; C < A,E
Data are presented as mean (standard deviation); a higher scores indicate worse health; b lower scores indicate poorer functioning
WILKS LAMBDA 0.80, F = 11.97, num df = 20; den df = 3546.4; p < 0.001
Table 2 Adjusted mean scores for the SDQ scale across the six groups with co-existing disorders
SDQ scale ADHD-only (A) ADHD + ADHD + ADHD + TIC/ ADHD + COORD (E) ADHD + Homogenous subsets
ANX/DEP (B) ODD/CD (C) Tourette’s (D) ≥2 COND (F)
Total Difficultiesa 18.6 (5.6) 20.1 (5.7) 21.5 (5.6) 19.3 (5.7) 18.4 (5.6) 23.1 (5.6) F > A,B,C,D,E; C > A,E
Emotional Symptomsb 3.7 (2.3) 5.1 (2.3) 4.1 (2.3) 4.6 (2.4) 3.9 (2.3) 5.1 (2.3) B,F > A,C,E
Conduct Problemsb 3.9 (2.2) 3.6 (2.2) 5.4 (2.2) 3.8 (2.3) 3.5 (2.2) 4.9 (2.2) F > A,B,E; C > A,B,D,E
Hyperactivity/Inattentionb 7.9 (1.7) 7.9 (1.7) 8.2 (1.7) 7.7 (1.7) 8.0 (1.7) 8.5 (1.7) F > A,E
Peer Relationship Problemsb 3.1 (2.4) 3.5 (2.4) 3.8 (2.4) 3.3 (2.4) 3.1 (2.4) 4.6 (2.4) F > A,B,C,D,E; C > A,E
Prosocial Behaviourb 7.4 (2.2) 7.5 (2.2) 6.4 (2.2) 7.5 (2.3) 7.5 (2.2) 6.5 (2.2) C,F < A,B,E
Data are presented as mean (standard deviation)
a range 0–40, ‘abnormal’ score ≥17 [based on UK norms]
b range 0–10, ‘abnormal’ score ≥4 (conduct problems), ≥5 (emotional symptoms), ≥7 (hyperactivity/inattention), > 4 (peer relationship problems), ≤4 (prosocial behav-
iour) [based on UK norms]
WILKS LAMBDA 0.82, F = 10.58, num df = 25; den df = 4797.4; p < 0.001
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ADHD-only group (Group A) and various other groups
on the SDQ subscale. As expected, the ADHD plus
ANX/DEP group (Group B) scored significantly worse
on the emotional symptoms scale compared with the
ADHD-only group and the groups with either co-exist-
ing ODD/CD or co-ordination problems.
Finally, comparisons of the six groups with co-exist-
ing disorders for the quality of life domains of the CHIP-
CE are shown in Table 3. Once again, the pattern was
consistent with the findings for the other scales. The
multiple problems group (Group F) displayed signifi-
cantly greater quality of life impairment (i. e. lower
scores) in all CHIP-CE domains compared with most
other groups. For the two domains of Risk Avoidance
and Resilience, the ADHD plus ODD/CD group (Group
C) showed the same pattern and this group also had sig-
nificantly more impairment in the Comfort and
Achievement domains than the ADHD-only group
(Group A). The ADHD only group had significantly
higher scores (indicating better quality of life) in the
Satisfaction domain than all other single co-existing
problems groups except the ADHD plus COORD prob-
lems (Group E) and ADHD plus tics/Tourette’s (Group
D).
Discussion
Co-existing problems not only represent an important
issue of theoretical reasoning,but also are common both
in the general population and in clinical samples. The
ADORE study, with its large sample taken from 10 Euro-
pean countries, has allowed us to investigate the impact
of co-existing psychiatric problems on the expression of
ADHD and overall functioning. The term “co-existence”
was preferred over “co-morbidity” in the present paper
because it is more appropriate for mental disorders in
general and for the design of the ADORE study specifi-
cally. The ADORE study did not perform a detailed as-
sessment of associated mental disorders, but rather only
asked for clinical overall ratings of various other psychi-
atric conditions. Besides sample differences, this diffe-
rence in methods may be one of the reasons why the
present study had a rather high proportion of coexisting
problems rather than the much lower rate of comorbid
anxiety, depression, and ODD ranging between 1.5 and
4.5 % in a recent European drug study based on struc-
tured psychiatric interviews [30]. The overall findings
were consistent across multiple measures of severity
and functioning. ADHD with multiple co-existing psy-
chiatric problems had important clinical consequences
in terms of greater severity of ADHD and behavioural
problems, poorer psychosocial functioning and greater
impairment of quality of life. To our knowledge, such a
consistent picture has not been demonstrated before for
ADHD. However, there is much concordance with indi-
vidual findings in the literature. The Oregon Adolescent
Depression Project demonstrated the varying clinical
consequences of different patterns of co-existing psy-
chiatric conditions, but did not include ADHD [17].
The evidence that ADHD in combination with
ODD/CD represents a valid subtype [2, 4, 14] is sup-
ported by the present study. In contrast, we found no ev-
idence to support the subtype of ADHD plus ANX/DEP.
The present findings also do not support the hypothesis
that ADHD in combination with tics/Tourette’s or DCDs
form valid nosological subtypes or increase the severity
of the clinical disorder. However, various studies have
found that the combination of ADHD and Tourette’s
syndrome is associated with more psychopathology and
poorer social adaptation than Tourette’s syndrome
alone [5, 10, 23]. Whilst ADHD and DCD are strongly
correlated and together are strongly associated with
ODD [15], this study indicates that their combination
does not necessarily lead to more behavioural problems.
The combination of ADHD with either tics/Tourette’s or
DCD may only exert a strong impact when multiple psy-
chiatric problems are present. Furthermore, the diffe-
rences in findings from other studies may be also due to
different approaches in study design and assessment.
In conclusion, the present findings in the large
ADORE cohort provide impressive evidence for the far-
reaching consequences of co-existing psychiatric prob-
lems in ADHD that need to be taken into account in clin-
ical practice.
Table 3 Adjusted mean scores (standardised) for the CHIP-CE scale across the six groups with co-existing disorders
CHIP-CE domain ADHD-only (A) ADHD + ANX/DEP (B) ADHD + ODD/CD (C) ADHD + TIC/ ADHD + COORD (E) ADHD + Homogenous subsets
Tourette’s (D) ≥2 COND (F)
Satisfactiona 36.1 (13.7) 30.0 (13.8) 32.4 (13.7) 35.6 (13.9) 32.7 (13.7) 25.1 (13.7) F < A,C,D,E; A > B,C,F
Comforta 44.3 (10.2) 41.2 (10.3) 41.0 (10.2) 42.0 (10.4) 43.0 (10.3) 37.5 (10.2) F < A,C,E; C < A
Risk Avoidancea 34.5 (12.9) 35.5 (13.0) 25.7 (12.9) 36.8 (13.1) 34.7 (12.9) 27.4 (12.9) C,F < A,B,D,E
Resiliencea 38.6 (11.9) 36.4 (12.0) 33.4 (11.9) 37.0 (12.1) 37.8 (11.9) 33.3 (11.9) C,F < A,E
Achievementa 33.2 (10.2) 30.9 (10.2) 29.6 (10.2) 34.5 (10.3) 31.4 (10.2) 25.6 (10.2) F < A,B,C,D,E; C < A
Data are presented as mean (standard deviation); a higher scores mean better quality of life
WILKS LAMBDA 0.82, F = 10.27, num df = 25; den df = 4626.5; p < 0.001
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